Clinical efficacy analysis of paxlovid in children with hematological diseases infected with the omicron SARS-CoV-2 new variant

OBJECTIVE: To summarize the clinical characteristics of children with hematological malignancies co-infected with novel coronavirus and explore the safety and effectiveness of Paxlovid treatment. METHODS: From December 10, 2022, to January 20, 2023, the clinical data of children with hematological d...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Yixian, Liu, Yong, Wen, Luping, Chen, Hui, Wang, Wenqing, Tian, Mengyao, Cheng, Yucai, Xue, Hongman, Chen, Chun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Pediatrics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10167044/
https://www.ncbi.nlm.nih.gov/pubmed/37181421
http://dx.doi.org/10.3389/fped.2023.1160929

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10167044/
https://www.ncbi.nlm.nih.gov/pubmed/37181421
http://dx.doi.org/10.3389/fped.2023.1160929

Ejemplares similares